Adopting the strategy of TA-expressing tumor-bearing mice generated with ST- or LT-expressing B16 melanomas cells to evaluate DNA vaccines targeting T antigen12,13, we established a murine CMS5 tumor cell line expressing MCV capsid protein VP1. The gene discussed is TBXT; the disease is melanoma.